Theragnostics Ltd: Developing New Radiotherapies Targeted To PARP
Prostate Cancer Is One Of The Initial Targets For Theragnostics' Technology
Emerging Company Profile: The transatlantic radiopharmaceuticals start-up Theragnostics Ltd. is developing radiotherapeutics and radiodiagnostics for prostate and other cancers.
